[Larotrectinib (solid tumours with neurotrophic tyrosine receptor kinase [NTRK] gene fusion) - Addendum to Commission A19-90]
Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018003665
German
Original Title:
Larotrectinib (solide Tumore mit einer neurotrophen Tyrosin-Rezeptor-Kinase[NTRK]-Genfusion) - Addendum zum Auftrag A19-90
Details
Project Status:
Completed
URL for project:
https://www.iqwig.de/projekte/a20-17.html
Year Published:
2020
URL for published report:
https://www.iqwig.de/download/A20-17_Larotrectinib_Addendum-zum-Auftrag-A19-90_V1-0.pdf
English language abstract:
There is no English language summary available
Publication Type:
Full HTA
Country:
Germany
MeSH Terms
- Neoplasms
- Gene Fusion
- Pyrazoles
- Pyrimidines
- Protein Kinase Inhibitors
Keywords
- Larotrectinib
- Neoplasms
- Gene Fusion
- Benefit Assessment
- NCT02122913
- NCT02576431
- NCT02637687
Contact
Organisation Name:
Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address:
IQWiG, Im Mediapark, 8, DE-50670 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email:
berichte@iqwig.de
Copyright:
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.